Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Nutr Sci Vitaminol (Tokyo) ; 68(6): 481-487, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36596545

RESUMEN

We previously demonstrated that ascorbic acid (AsA) deficiency, caused by an AsA-free diet, induces inflammatory changes in the liver and intestine of osteogenic disorder Shionogi (ODS) rats that cannot synthesize AsA. However, whether low AsA intake induces inflammatory changes remains unknown. Here, we assessed the inflammatory changes in ODS rats caused by low AsA intake and compared them to ODS rats that were fed a diet supplemented with sufficient amounts of AsA (300 mg/kg). Male ODS rats (12-wk-old) were fed an AsA-free diet (0 ppm group), AsA 20 mg/kg diet (20 ppm group), AsA 40 mg/kg diet (40 ppm group) or AsA 300 mg/kg diet (300 ppm group) for 22 d. The hepatic mRNA levels of acute phase proteins, including C-reactive protein (CRP) and haptoglobin, were higher in the 0 and 20 ppm groups, than in the 300 and 40 ppm groups, but were not significantly higher in the 20 ppm group. Serum CRP concentrations were significantly higher in the 0 and 20 ppm groups than in the 300 and 40 ppm groups. Jejunal and ileal interleukin-1ß (IL-1ß) mRNA levels were higher in the 0 and 20 ppm groups than in the 300 ppm group. Jejunal and ileal IL-6 mRNA levels tended to be higher in the 0 and 20 ppm groups than in the 300 ppm group. Furthermore, the portal IL-6 concentration gradually increased with decrease in the AsA intake. Thus, inflammatory changes could occur in both AsA-deficient ODS rats and ODS rats with low AsA intake.


Asunto(s)
Deficiencia de Ácido Ascórbico , Interleucina-6 , Ratas , Masculino , Animales , Hígado/metabolismo , Ácido Ascórbico , ARN Mensajero/metabolismo , Intestinos
2.
J Nutr Sci Vitaminol (Tokyo) ; 64(6): 404-411, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30606963

RESUMEN

The aim of this study was to verify the protective effects of ascorbic acid (AsA) against lipopolysaccharide (LPS)-induced sepsis. The study was conducted using osteogenic disorder Shionogi (ODS) rats, which are unable to synthesize AsA. Male ODS rats (6 wk old) were fed either an AsA-free diet (AsA-deficient group), a diet supplemented with 300 mg/kg AsA (control group), or a diet supplemented with 3,000 mg/kg AsA (high-AsA group) for 8 d. On day 8, all the rats were intraperitoneally injected with LPS (15 mg/kg body weight). Forty-eight hours after the injection, the survival rates of the rats in the control (39%) and the high-AsA (61%) groups were significantly higher than that in the AsA-deficient group (5.5%). Next, we measured several inflammatory parameters during 10 h after administering LPS. At 6 h, elevated serum levels of markers for hepatic and systemic injuries were suppressed in rats fed AsA. Similarly, 10 h after LPS injection, the elevation in the serum levels of markers for renal injury were also suppressed proportionally to the amount of AsA in the diet. The elevated serum concentrations of TNFα and IL-1ß by LPS in the AsA-deficient group decreased in groups fed AsA. Hematic TNFα mRNA levels at 6 h after the LPS injection were also lowered by feeding AsA. These results demonstrated that the dietary intake of AsA improved the survival rates and suppressed the inflammatory damage, in a dose-dependent manner, caused during sepsis induced by LPS in ODS rats.


Asunto(s)
Ácido Ascórbico/uso terapéutico , Suplementos Dietéticos , Inflamación/prevención & control , Riñón/efectos de los fármacos , Hígado/efectos de los fármacos , Sepsis/tratamiento farmacológico , Vitaminas/uso terapéutico , Animales , Antiinflamatorios/administración & dosificación , Antiinflamatorios/sangre , Antiinflamatorios/farmacología , Antiinflamatorios/uso terapéutico , Ácido Ascórbico/administración & dosificación , Ácido Ascórbico/sangre , Ácido Ascórbico/farmacología , Deficiencia de Ácido Ascórbico/sangre , Deficiencia de Ácido Ascórbico/complicaciones , Deficiencia de Ácido Ascórbico/genética , Deficiencia de Ácido Ascórbico/prevención & control , Dieta , Inflamación/inducido químicamente , Interleucina-1beta/sangre , Enfermedades Renales/sangre , Enfermedades Renales/etiología , Enfermedades Renales/prevención & control , Lipopolisacáridos , Hepatopatías/sangre , Hepatopatías/etiología , Hepatopatías/prevención & control , Masculino , Estado Nutricional , Osteogénesis/fisiología , Ratas , Ratas Endogámicas , Sepsis/inducido químicamente , Sepsis/complicaciones , Factor de Necrosis Tumoral alfa/sangre , Vitaminas/administración & dosificación , Vitaminas/sangre , Vitaminas/farmacología
3.
J Nutr Sci Vitaminol (Tokyo) ; 63(3): 200-207, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28757535

RESUMEN

Coffee consumption reduces the risk of type 2 diabetes in humans, but the mechanism remains unclear. In this study, we investigated the effect of coffee on pancreatic ß-cells in the induction of diabetes by streptozotocin (STZ) treatment in mice. We examined the effect of coffee, caffeine, or decaffeinated coffee ingestion on STZ-induced hyperglycemia. After STZ injection in Exp. 1 and 2, serum glucose concentration and water intake in coffee ingestion (Coffee group) tended to be lowered or was significantly lowered compared to those in water ingestion (Water group) instead of coffee. In Exp. 1, the values for water intake and serum glucose concentration in caffeine ingestion (Caffeine group) were similar to those in the Water group. In Exp. 2, serum glucose concentrations in the decaffeinated coffee ingestion (Decaf group) tended to be lower than those in the Water group. Pancreatic insulin contents tended to be higher in the Coffee and Decaf groups than in the Water group (Exp. 1 and 2). In Exp. 3, subsequently, we showed that coffee ingestion also suppressed the deterioration of hyperglycemia in diabetic mice which had been already injected with STZ. This study showed that coffee ingestion prevented the development of STZ-induced diabetes and suppressed hyperglycemia in STZ-diabetic mice. Caffeine or decaffeinated coffee ingestion did not significantly suppress STZ-induced hyperglycemia. These results suggest that the combination of caffeine and other components of decaffeinated coffee are needed for the preventive effect on pancreatic ß-cell destruction. Coffee ingestion may contribute to the maintenance of pancreatic insulin contents.


Asunto(s)
Café , Diabetes Mellitus Experimental/prevención & control , Hiperglucemia/sangre , Animales , Glucemia/metabolismo , Cafeína/farmacología , Hiperglucemia/prevención & control , Insulina/sangre , Células Secretoras de Insulina/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos C57BL , Páncreas/efectos de los fármacos
4.
J Nutr Sci Vitaminol (Tokyo) ; 58(6): 408-14, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23419399

RESUMEN

Coffee has an anti-diabetic effect, specifically the amelioration of both hyperglycemia and insulin resistance, in KK-A(y) mice, a type 2 diabetes animal model. To investigate coffee's effect on insulin signaling in liver, skeletal muscle, and adipose tissue (epididymal fat), we assayed the tyrosine phosphorylation of insulin receptor (IR) and serine phosphorylation of Akt. In Expt. 1, we assayed insulin signaling under nonfasting conditions in KK-A(y) mice that ingested water or coffee for 4 wk. Coffee ingestion ameliorated the development of hyperglycemia but did not affect insulin signaling in liver or skeletal muscle under such conditions. In Expt. 2, we assayed insulin signaling under basal and insulin-stimulated conditions in KK-A(y) mice that ingested water or coffee for 3 wk. The levels of tyrosine phosphorylation of insulin receptor in response to insulin injection in insulin-sensitive tissues were not different between mice that drank water and those that drank coffee. Coffee ingestion significantly increased the insulin-induced serine phosphorylation of Akt in liver and skeletal muscle, but not in epididymal fat, of KK-A(y) mice. Our results also indicated that coffee ingestion may contribute to the improvement of insulin resistance and hyperglycemia in KK-A(y) mice via the activation of Akt in insulin signaling in liver and skeletal muscle.


Asunto(s)
Café/metabolismo , Diabetes Mellitus Experimental/tratamiento farmacológico , Insulina/sangre , Hígado/efectos de los fármacos , Músculo Esquelético/efectos de los fármacos , Proteínas Proto-Oncogénicas c-akt/metabolismo , Tejido Adiposo/efectos de los fármacos , Animales , Glucemia/análisis , Peso Corporal , Hiperglucemia/tratamiento farmacológico , Hipoglucemiantes/farmacología , Resistencia a la Insulina , Hígado/metabolismo , Masculino , Ratones , Músculo Esquelético/metabolismo , Fosforilación , Proteínas Proto-Oncogénicas c-akt/genética , Receptor de Insulina/metabolismo , Serina/metabolismo , Transducción de Señal , Tirosina/metabolismo
5.
Biosci Biotechnol Biochem ; 75(12): 2309-15, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22146708

RESUMEN

We have previously demonstrated that coffee and caffeine ameliorated hyperglycemia in spontaneously diabetic KK-A(y) mice. This present study evaluates the antidiabetic effects of coffee and caffeine on high-fat-diet-induced impaired glucose tolerance in C57BL/6J mice. C57BL/6J mice fed a high-fat diet were given regular drinking water (control group), or a 2.5-fold-diluted coffee or caffeine solution (200 mg/L) for 17 weeks. The ingestion of coffee or caffeine improved glucose tolerance, insulin sensitivity, and hyperinsulinemia when compared with mice in the control group. The adipose tissue mRNA levels of inflammatory adipocytokines (MCP-1 and IL-6) and the liver mRNA levels of genes related to fatty acid synthesis were lower in the coffee and caffeine groups than those in the control group. These results suggest that coffee and caffeine exerted an ameliorative effect on high-fat-diet-induced impaired glucose tolerance by improving insulin sensitivity. This effect might be attributable in part to the reduction of inflammatory adipocytokine expression.


Asunto(s)
Glucemia/metabolismo , Cafeína/farmacología , Café , Dieta Alta en Grasa/efectos adversos , Hipoglucemiantes/farmacología , Insulina/metabolismo , Adipoquinas/genética , Tejido Adiposo/efectos de los fármacos , Tejido Adiposo/metabolismo , Animales , Ingestión de Alimentos , Ácidos Grasos/biosíntesis , Regulación de la Expresión Génica/efectos de los fármacos , Prueba de Tolerancia a la Glucosa , Resistencia a la Insulina , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , ARN Mensajero/genética , ARN Mensajero/metabolismo
6.
J Agric Food Chem ; 58(9): 5597-603, 2010 May 12.
Artículo en Inglés | MEDLINE | ID: mdl-20405946

RESUMEN

Epidemiological surveys have demonstrated that habitual coffee consumption reduces the risk of type 2 diabetes. The aim of this work was to study the antidiabetic effect of coffee and caffeine in spontaneously diabetic KK-A(y) mice. KK-A(y) mice were given regular drinking water (controls) or 2-fold diluted coffee for 5 weeks. Coffee ingestion ameliorated the development of hyperglycemia and improved insulin sensitivity. White adipose tissue mRNA levels of inflammatory cytokines (MCP-1, IL-6, and TNFalpha), adipose tissue MCP-1 concentration, and serum IL-6 concentration in the coffee group were lower than the control group. Moreover, coffee ingestion improved the fatty liver. Caffeine ingestion as drinking water also caused an amelioration of hyperglycemia and an improvement of fatty liver. These results suggest that coffee exerts a suppressive effect on hyperglycemia by improving insulin sensitivity, partly due to reducing inflammatory cytokine expression and improving fatty liver. Moreover, caffeine may be one of the effective antidiabetic compounds in coffee.


Asunto(s)
Adipoquinas/metabolismo , Cafeína/farmacología , Café/química , Diabetes Mellitus Experimental/metabolismo , Hígado Graso/prevención & control , Hiperglucemia/prevención & control , Adipoquinas/genética , Animales , Glucemia/análisis , Ratones , ARN Mensajero/genética
7.
Int J Mol Med ; 16(6): 1015-20, 2005 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16273280

RESUMEN

To investigate whether in vivo gene transfer causes leptin-antagonistic effects on food intake, animal body weight and fat tissue weight, the R128Q mutated-leptin gene, an R to Q substitution at position 128 of mouse leptin, was transferred into mouse liver and leg muscle by electroporation and hydrodynamics-based gene delivery. Mutated-leptin gene transfer by electroporation caused significant increases in body weight at 5 days and after (5.4% increase relative to control; p<0.05). Hydrodynamics-based gene delivery of the mutated-leptin gene also caused an increase in body weight (3.0% increase relative to control; p<0.05). Mutated-leptin gene transfer by electroporation significantly increased the tissue weight of epididymal white fat and neuropeptide Y mRNA expression in the hypothalamus compared with those of the control group 3 weeks after gene transfer (p<0.05). These results suggest that mutated-leptin gene transfer successfully produced leptin-antagonistic effects by modulating the central regulator of energy homeostasis. Also, the extent of leptin-antagonistic effects by electroporation was much higher than hydrodynamics-based gene delivery, with at least single gene transfer.


Asunto(s)
Peso Corporal/genética , Electroporación/métodos , Técnicas de Transferencia de Gen , Leptina/genética , Leptina/metabolismo , Mutación/genética , Tejido Adiposo Pardo , Proteína Relacionada con Agouti , Animales , Proteínas Portadoras/metabolismo , Ingestión de Alimentos , Metabolismo Energético , Hipotálamo , Péptidos y Proteínas de Señalización Intercelular , Canales Iónicos , Leptina/sangre , Masculino , Proteínas de la Membrana/metabolismo , Ratones , Ratones Endogámicos ICR , Proteínas Mitocondriales , Neuropéptido Y/metabolismo , Mutación Puntual , Proteínas/genética , Proteínas/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Análisis de Secuencia de ADN , Proteína Desacopladora 1
8.
Neurosci Lett ; 370(2-3): 108-13, 2004 Nov 11.
Artículo en Inglés | MEDLINE | ID: mdl-15488304

RESUMEN

In the present study, the cDNA encoding agouti-related protein (AGRP) gene known as an orexigenic factor was transferred in vivo to test whether food intake and body weight gain is improved in mice. When the expression plasmid of AGRP gene driven by mouse beta-actin, pActAGRP, was transferred into leg muscle by electroporation, body weight of gene-transferred mice was significantly increased at 14 days and afterwards compared with that of control counterparts (p < 0.05). Likewise, daily food intake was also significantly higher in the AGRP gene-transferred mice than in the control mice at 4 days and afterwards (p < 0.05). A significant increase in serum AGRP concentration of the AGRP gene-transferred group was detected compared with the control group at 1 week (p < 0.01), but the difference quickly disappeared at 3 weeks. However, the hypothalamic NPY mRNA abundance of AGRP gene-transferred mice was significantly higher than that of the control mice at 3 weeks (p < 0.05). These results suggested that instead of hormone administration per se, in vivo AGPR gene transfer into skeletal muscle was found to mimic hormonal effects. The present methodology of in vivo gene transfer by electroporation might be useful to promote growth and food intake in farm livestock as well as experimental animals.


Asunto(s)
Peso Corporal/fisiología , Ingestión de Alimentos/fisiología , Electroporación , Proteínas/fisiología , Proteína Relacionada con Agouti , Animales , Western Blotting/métodos , Ensayo de Inmunoadsorción Enzimática/métodos , Expresión Génica/genética , Técnicas de Transferencia de Gen , Proteínas Fluorescentes Verdes/genética , Proteínas Fluorescentes Verdes/metabolismo , Humanos , Hipotálamo/metabolismo , Péptidos y Proteínas de Señalización Intercelular , Masculino , Ratones , Ratones Endogámicos ICR , Músculos/metabolismo , Neuropéptido Y/metabolismo , Tamaño de los Órganos/genética , Proteínas/genética , ARN Mensajero/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Factores de Tiempo
9.
Neurosci Lett ; 341(2): 135-8, 2003 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-12686384

RESUMEN

Conjugated linoleic acids (CLA) are naturally occurring fatty acids that have been recognized to modify prostaglandin (PG) production in specific tissues. So far, no relationship between PG production and CLA has been reported in the brain. Thus, the effects of CLA on cerebral prostaglandin E(2) (PGE(2)) levels and cyclooxygenase (COX)-1 and COX-2 mRNA expression in mice were determined in the present study. Mice given the diet with or without 3% CLA at the age of 9 weeks were mated, reproduced and lactated. Offspring mice given each diet until 25 days and 8 weeks of age were sacrificed and their brains removed. Production of PGE(2) was reduced while COX mRNA was quantitatively increased by CLA supplementation. These results imply that brain PGE(2) production can be reduced by dietary CLA without inhibition of COX gene expression in mice.


Asunto(s)
Corteza Cerebral/efectos de los fármacos , Grasas de la Dieta/farmacología , Dinoprostona/metabolismo , Ácido Linoleico/farmacología , Animales , Corteza Cerebral/metabolismo , Dinoprostona/genética , Ingestión de Alimentos/efectos de los fármacos , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Masculino , Ratones , Prostaglandina-Endoperóxido Sintasas/clasificación , Prostaglandina-Endoperóxido Sintasas/genética , ARN Mensajero/biosíntesis , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA